OPERA 2025: Jennifer Stevenson Introducing the first member of the OPERA 2025 shortlist, Jennifer Stevenson, lead pharmacist for older adults at Guy’s and St Thomas’ NHS Foundation Trust, and an honorary senior lecturer at King’s College London.…
RPS asked for clarification on dispensing timelines following death of patient with diabetes A coroner has issued a ‘Prevention of future deaths’ report seeking information on a repeat prescribing toolkit published by the Royal Pharmaceutical Society and Royal College of GPs.…
More than 20% increase in pharmacists working in pharmacotherapy over past five years The Scottish government said that the number of pharmacy technicians working in pharmacotherapy has increased by almost 90% since 2021.…
Pharmacy First uptake ‘not what we would like it to be’, says minister Pharmacy minister Stephen Kinnock said that the government will work to reform the financial arrangements for Pharmacy First to incentivise pharmacists to embrace the scheme.…
Test your knowledge of neurodevelopment and neurological conditions From ADHD and autism, to multiple sclerosis and seizure disorders, neurological conditions affect a huge proportion of the UK population. Here, test your knowledge of these common and often complex conditions.…
Spending review 2025: providers urge government to invest in primary care Pharmacy leaders argue the latest government spending review allocations represent a “missed opportunity to put pharmacies first”.…
People with sickle cell disease face racism and ‘sub-standard care’, finds report A report commissioned by the NHS Race and Health Observatory recommends that more sickle cell training for healthcare professionals, including primary care, is needed.…
GPhC highlights need to improve performance in five-year strategy To meet its goals under its strategic plan for 2025–2030, the regulator said it must improve its fitness-to-practise processes, streamline investigations and ensure financial stability.…
NICE rejects Alzheimer’s disease drugs for third time The National Institute for Health and Clinical Excellence said the benefits of donanemab and lecanemab in the treatment of Alzheimer's disease are too small to justify their high costs to the NHS.…
Sam Appiah-Anane: ‘We should all really be allies for each other’ The president of the UK Black Pharmacist Association discusses the organisation's mentoring programme and its efforts to support black pharmacists.…
